Jpmorgan Chase & CO Tff Pharmaceuticals, Inc. Transaction History

Jpmorgan Chase & CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.31 - $0.48 $18 - $29	61 New	61 $0
Q2 2022 Aug 11, 2022	SELL	$3.99 - $7.22 $10,274 - $18,591	-2,575 Reduced 5.63%	43,133 $244,000
Q1 2022 May 11, 2022	SELL	$5.28 - $9.17 $98,144 - $170,451	-18,588 Reduced 28.91%	45,708 $288,000
Q4 2021 Feb 10, 2022	SELL	$6.86 - $9.65 $92,630 - $130,303	-13,503 Reduced 17.36%	64,296 $570,000
Q3 2021 Nov 12, 2021	BUY	$7.21 - $10.49 $560,930 - $816,111	77,799 New	77,799 $601,000

Ticker TFFP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,477,800
Market Cap $8.66M
Description
TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and condit...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.